Clinical Trial for Long-Lasting Injectable Opioid Dependence Treatment Succeeds

Potentially adds to stable treatments for growing epidemic of opioid abuse

A technician empties pills containing heroin, from a batch of street-level drugs, to be tested at a Drug Enforcement Agency lab.
A technician empties pills containing heroin, from a batch of street-level drugs, to be tested at a Drug Enforcement Agency lab. PHOTO:T.J. KIRKPATRICK FOR THE WALL STREET JOURNAL
.

Updated Nov. 14, 2016 10:34 a.m. ET

A late-stage trial for an injectable treatment for addiction to heroin and other opioids was successful, potentially adding to the stable of treatments for the growing epidemic of opioid abuse, Braeburn Pharmaceuticals and Camurus AB said Monday.

The trial follows a May U.S. Food and Drug Administration approval of another treatment option from Braeburn: a long-lasting arm implant that provides six months’ worth of the drug—buprenorphine.

Full results of the study are expected to be presented at a conference in April and the company then plans to submit the drug for approval by mid-2017.

The new weekly and monthly injection option could potentially help more addicts stay on the drug, which eases cravings for opioids and prevents withdrawal symptoms. Buprenorphine is currently available as tablets and films that dissolve in the mouth, the company said. Addicts sometimes run out of doses or skip them and use narcotics instead, or sell them to other addicts.

More than 47,000 Americans died of drug overdoses in 2014 and about 650,000 Americans received buprenorphine to treat opioid addiction in 2014.

Safety profiles were comparable between the two treatment groups, with few serious adverse events.

The Phase 3 study enrolled 428 patients with opioid use disorder and exceeded its original goal by being superior to the current tablet treatment. Phase 3 clinical trials are typically the last phase before a drug seeks FDA approval.

Shares of Camurus rose 16% in Stockholm trading Monday.

Write to Austen Hufford at austen.hufford@wsj.com

http://www.wsj.com/articles/clinical-trial-for-long-lasting-injectable-opioid-dependence-treatment-succeeds-1479131851

Tags: , , , , , , , ,

One Response to “Clinical Trial for Long-Lasting Injectable Opioid Dependence Treatment Succeeds”

  1. daveyone1 Says:

    Reblogged this on World Peace Forum.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: